The Minara Chamber of Commerce, South Africa, recently hosted a webinar on the use of Ivermectin in the treatment of Covid-19. The webinar was attended by over 450 doctors, researchers, academics and public and private sector representatives. Dr Pierre Kory responded to the South African National Department of Health’s “rapid review” and presented meta-analysis research…
Category: Africa
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
In March 2020, an expert panel called the Front Line COVID-19 Critical Care Alliance (FLCCC) was created and led by Professor Paul E. Marik, with the goal of continuously reviewing the rapidly emerging basic science, translational, and clinical data in order to gain insight into and to develop a treatment protocol for COVID-19. At the…
South African National Department of Health recommends Ivermectin for further clinical trials
In a “rapid review” of Ivermectin for Covid-19 the South African National Department of Health recommended that eligible patients with Covid‐19 in South Africa should be considered for enrolment in relevant therapeutic trials, but did not endorse the drug for general treatment of Covid-19 patients. “The evidence of efficacy and safety is very uncertain at…